Sponsor pipeline

XBiotech, Inc. clinical trial pipeline

Get alerts when XBiotech, Inc.'s trials change

2 active trials 0 recruiting 2 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-05
Primary endpoint(s) modified
Trial completed
NCT04825288 XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer · Phase 1/2

Active trials by phase

Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06526377 Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy Axial Spondyloarthritis Not Yet Recruiting 2026-05-14
NCT06590090 Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment Rheumatoid Arthritis Not Yet Recruiting 2025-12-09

Disease areas by active trials

Ankylosing Spondylitis (1) · Rheumatoid Arthritis (1)

Get alerts when XBiotech, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free